Results

Adventist Health System Sunbelt Healthcare Corporation

11/17/2026 | Press release | Distributed by Public on 11/18/2026 18:12

AdventHealth Tampa introduces noninvasive ultrasound treatment for liver tumors

Iswanto Sucandy, MD, leads AdventHealth Tampa's liver program

TAMPA, Fla. - Tampa resident Rosemary Levy walks every day, works out with her son twice a week and eats healthy. The 64-year-old has a strong support system as she navigates life with neuroendocrine cancer, an uncommon type of cancer that starts in neuroendocrine cells.

Now, she also has a unique treatment option that she hopes will give her more time with the people she loves.

Levy successfully became the first patient at AdventHealth Tampa to receive histotripsy, a noninvasive procedure that uses focused ultrasound waves to destroy targeted liver tumor tissue without an incision.

"The fact that I have this option really eases my mind," Levy said. "I know I won't be cured, but I have a nonsurgical option that could help get rid of the tumors."

Histotripsy uses focused sound waves to create tiny bubbles within targeted tissue. As the bubbles rapidly form and collapse, they mechanically break down the tissue without using heat or radiation.

Because histotripsy does not require a surgical incision, patients with primary and metastatic liver tumors can be treated without stopping their chemotherapy treatment or while they are on anticoagulation, commonly called blood thinners.

The procedure adds another option for certain patients with liver tumors, including some whose tumors cannot be safely removed surgically.

By offering histotripsy, AdventHealth Tampa is making the treatment available closer to home for eligible patients and the family members and friends who support them.

"A liver tumor diagnosis can bring uncertainty for patients and their families, and finding the right treatment is deeply personal," said Iswanto Sucandy, MD, who leads AdventHealth Tampa's liver program. "Our goal is to understand each patient's needs and give them access to care options close to the people and places that matter most to them."

The HistoSonics Edison System received U.S. Food and Drug Administration authorization for the noninvasive destruction of liver tumors, including unresectable tumors, in 2023.

AdventHealth's West Florida digestive health program cares for people with liver conditions, including various liver cancers, fatty liver disease and viral hepatitis.

Dr. Sucandy's work includes care for liver tumors, including cancer that begins in the liver and cancer that has spread there from another any parts of the body.

For Levy, she sees a future where she can continue with histotripsy and potentially get off a harsh medication she's had to take to reduce the size of her tumors.

"I have five other tumors, but they're so small they can't see them on the ultrasound. If they grow, we can hopefully treat those, too. If it's possible that I won't need the lanreotide shots anymore, I would love that."

For more information about the Digestive Health Institute at AdventHealth Tampa, click here.

Adventist Health System Sunbelt Healthcare Corporation published this content on November 17, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 19, 2026 at 00:12 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]